Drug Repositioning: Current Advances and Future Perspectives

Drug repositioning is the process of identifying new indications for existing drugs. At present, the conventional de novo drug discovery process requires an average of about 14 years and US$2.5 billion to approve and launch a drug. Drug repositioning can reduce the time and cost of this process beca...

Descripción completa

Detalles Bibliográficos
Otros Autores: Yuhei Nishimura (auth), Hideaki Hara
Formato: Libro electrónico
Idioma:Inglés
Publicado: Frontiers Media SA 2019
Colección:Frontiers Research Topics
Materias:
Ver en Biblioteca Universitat Ramon Llull:https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009420558006719

Ejemplares similares